| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |